| Dr Pablo Mojica, MD | |
|
1901 E Center St, Anaheim, CA 92805-3457 | |
| (714) 780-0750 | |
| Not Available |
| Full Name | Dr Pablo Mojica |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1901 E Center St, Anaheim, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043231301 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | C37850 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pablo Mojica, MD 1901 E Center St, Anaheim, CA 92805-3457 Ph: (714) 780-0750 | Dr Pablo Mojica, MD 1901 E Center St, Anaheim, CA 92805-3457 Ph: (714) 780-0750 |
News Archive
A drug originally developed to prevent the rejection of transplanted organs has now been shown to dramatically reduce seizures in patients with tuberous sclerosis complex - a genetic disease characterized by benign tumors on multiple organ systems.
Conservative interest groups and Republican lawmakers want Justice Elena Kagan off the health care case. Liberals and Democrats in Congress say it's Justice Clarence Thomas who should sit it out. Neither justice is budging -; the right decision, according to many ethicists and legal experts.
Scientists are reporting development and testing of a new series of drugs that could finally stop the fox tapeworm - which causes a rare but life-threatening disease in humans - dead in its tracks. The report, which appears in ACS' Journal of Medicinal Chemistry, shows that specific organometallic substances that help combat cancer are also the surprising best new hope for a treatment against tapeworm infection.
As females age, their bodies typically undergo two significant changes that generally occur during adolescence and middle age.
New findings presented today during the APASL Liver Week in Singapore, highlighted the efficacy and safety of faldaprevir+ plus pegylated interferon and ribavirin (PegIFN/RBV) in treatment-naïve patients with genotype-1 hepatitis C virus (HCV) in Asia.1 This post-hoc sub-analysis of the Phase III STARTVerso™1 and 2 trials showed that both doses of faldaprevir were associated with high viral cure rates and a shorter treatment duration in this particular patient group.1
› Verified 7 days ago
Dr. Onsi Habeeb El-zayat, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1020 S Anaheim Blvd Ste 214, Anaheim, CA 92805 Phone: 714-776-3371 Fax: 714-776-0230 | |
Dr. Chung-lim Kim, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1900 E La Palma Ave Ste 101, Anaheim, CA 92805 Phone: 714-399-3480 Fax: 714-399-3481 | |
Dr. Michael James Wexler, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2035 E Ball Rd Ste 200, Anaheim, CA 92806 Phone: 714-517-6300 Fax: 714-517-6306 | |
Dr. Vuong Duc Nguyen, M. D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2035 E Ball Rd, Anaheim, CA 92806 Phone: 714-517-6300 | |
Susan E. Skinner, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Sirichai Chayasirisobhon, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 |